Exploring the Interaction of Cobalt Oxide Nanoparticles with Albumin, Leukemia Cancer Cells and Pathogenic Bacterial by Multispectroscopic, Docking, Cellular and Antibacterial Approaches
Open Access
- 1 June 2020
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 15, 4607-4623
Abstract
Aim: The interaction of NPs with biological systems may reveal useful details about their pharmacodynamic, anticancer and antibacterial effects. Methods: Herein, the interaction of as-synthesized Co3O4 NPs with HSA was explored by different kinds of fluorescence and CD spectroscopic methods, as well as molecular docking studies. Also, the anticancer effect of Co3O4 NPs against leukemia K562 cells was investigated by MTT, LDH, caspase, real-time PCR, ROS, cell cycle, and apoptosis assays. Afterwards, the antibacterial effects of Co3O4 NPs against three pathogenic bacteria were disclosed by antibacterial assays. Results: Different characterization methods such as TEM, DLS, zeta potential and XRD studies proved that fabricated Co3O4 NPs by sol-gel method have a diameter of around 50 nm, hydrodynamic radius of 177 nm with a charge distribution of − 33.04 mV and a well-defined crystalline phase. Intrinsic, extrinsic, and synchronous fluorescence as well as CD studies, respectively, showed that the HSA undergoes some fluorescence quenching, minor conformational changes, microenvironmental changes as well as no structural changes in the secondary structure, after interaction with Co3O4 NPs. Molecular docking results also verified that the spherical clusters with a dimension of 1.5 nm exhibit the most binding energy with HSA molecules. Anticancer assays demonstrated that Co3O4 NPs can selectively lead to the reduction of K562 cell viability through the cell membrane damage, activation of caspase-9, -8 and -3, elevation of Bax/Bcl-2 mRNA ratio, ROS production, cell cycle arrest, and apoptosis. Finally, antibacterial assays disclosed that Co3O4 NPs can stimulate a promising antibacterial effect against pathogenic bacteria. Conclusion: In general, these observations can provide useful information for the early stages of nanomaterial applications in therapeutic platforms.Keywords
This publication has 71 references indexed in Scilit:
- Comparative cytotoxicity and genotoxicity of cobalt (II, III) oxide, iron (III) oxide, silicon dioxide, and aluminum oxide nanoparticles on human lymphocytes in vitroHuman & Experimental Toxicology, 2015
- Toxicity of cobalt oxide nanoparticles to normal cells; an in vitro and in vivo studyChemico-Biological Interactions, 2015
- SYNTHESIS, CHARACTERIZATION AND ANTIBACTERIAL ACTIVITY OF COBALT(III) COMPLEX WITH PHENANTHROLINE AND MALTOSEJournal of the Chilean Chemical Society, 2014
- The role of cobalt ferrite magnetic nanoparticles in medical scienceMaterials Science and Engineering: C, 2013
- Co3O4 nanocrystals on graphene as a synergistic catalyst for oxygen reduction reactionNature Materials, 2011
- Predictive Toxicology of Cobalt Nanoparticles and Ions: Comparative In Vitro Study of Different Cellular Models Using Methods of Knowledge Discovery from DataToxicological Sciences, 2011
- The Influence of Surface Composition of Nanoparticles on their Interactions with Serum AlbuminChemphyschem, 2010
- Cobalt Complexes as Antiviral and Antibacterial AgentsPharmaceuticals, 2010
- Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitroMutagenesis, 2008
- Evidence that the Principal CoII-Binding Site in Human Serum Albumin Is Not at the N-Terminus: Implication on the Albumin Cobalt Binding Test for Detecting Myocardial IschemiaBiochemistry, 2007